EP2710107A1 - Composition désinfectante - Google Patents

Composition désinfectante

Info

Publication number
EP2710107A1
EP2710107A1 EP12719416.5A EP12719416A EP2710107A1 EP 2710107 A1 EP2710107 A1 EP 2710107A1 EP 12719416 A EP12719416 A EP 12719416A EP 2710107 A1 EP2710107 A1 EP 2710107A1
Authority
EP
European Patent Office
Prior art keywords
sanitising
composition according
sanitising composition
active
thickener
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12719416.5A
Other languages
German (de)
English (en)
Inventor
Peter Finan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MTP Innovations Ltd
Original Assignee
MTP Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1103123.4A external-priority patent/GB201103123D0/en
Priority claimed from GBGB1118303.5A external-priority patent/GB201118303D0/en
Application filed by MTP Innovations Ltd filed Critical MTP Innovations Ltd
Publication of EP2710107A1 publication Critical patent/EP2710107A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/37—Polymers
    • C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C11D3/373—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicones
    • C11D3/3734—Cyclic silicones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients

Definitions

  • This invention relates to sanitising compositions. More particularly, but not exclusively, this invention relates to sanitising compositions in the form of gels. Embodiments of the invention relate to sanitising compositions for use in cleaning the skin, particularly the skin of a person's hands.
  • Such sanitising gels generally comprise sodium laureth sulphate and cocamidopropyl betaine, and may include anti-bacterial ingredients, such as triclosan, triclocarban and polyhexamethylene biguanide. Also, many known hand gels use an alcohol base. However, they are not entirely satisfactory in performance.
  • a sanitising composition comprising a carrier comprising a cyclic polysiloxane, and the composition further including an active sanitising ingredient system.
  • a method of manufacturing a sanitising composition comprising providing a carrier comprising a cyclic polysiloxane and mixing an active sanitising ingredient system therewith.
  • the cyclic polysiloxane may comprise one or more selected from cyclotetrasiloxane and cyclopentasiloxane.
  • the cyclic polysiloxane is cyclopentasiloxane.
  • the use of a cyclic polysiloxane has the advantage that the sanitising composition can be applied to the skin of a person in a smooth, even manner.
  • the cyclic polysiloxane also provides the advantage in the embodiment described herein, that it evaporates leaving behind the active ingredient.
  • the active sanitising ingredient system may comprise a cationic ingredient.
  • the active sanitising ingredient system may comprise one or more quaternary ammonium compounds.
  • the active sanitising ingredient system comprises at least two, for example three, different quaternary ammonium compounds.
  • the quaternary ammonium compounds may be selected from the group consisting of polyaminopropyl biguanide, didecyldimethyl ammonium chloride and benzalkonium chloride.
  • the active sanitising ingredient system may comprise one or more active sanitising ingredient components selected from polyaminopropyl biguanide, didecyl dimethyl ammonium chloride, chlorhexidine digluconate and benzalkonium chloride.
  • the active sanitising ingredient system may further comprise a chlorophenol.
  • the cholorophenol may be selected from the group consisting of 2,4,6-Trichlorophenol, Pentachlorophenol, 4-chloro-3-methylphenol (chlorocresol), PCMX (4-chloro-3,5- dimethylphenol, or para-chloro-meta-xylenol), DCMX (2,4-dichloro-3,5-dimethylphenol, or dichloro-meta-xylenol), PCMC (4-chloro-3-methylphenol, or para-chloro-meta-cresol) Monochloro-2-phenylphenol, OBPCP (2-benzyl-4-chlorophenol, or chlorphen, or ortho- benzyl-para-chlorophenol) and 2,4-dichlorobenzyl alcohol.
  • the chlorophenol component is parachlorometaxylenol (PCMX) (otherwise known as chloroxylenol).
  • the active sanitising ingredient system may further comprise a water soluble ether and/or alcohol component.
  • the alcohol is preferably not ethanol or isopropyl alcohol, for example the water soluble alcohol component may be butanol.
  • the active sanitising ingredient system comprises a water soluble ether alcohol component for example methoxymethylbutanol.
  • the active sanitising ingredient system comprises methoxymethylbutanol.
  • the use of methoxymethylbutanol acts as a solvent for the PCMX component thus enabling it to be added to the aqueous phase.
  • the methoxymethylbutanol also aids the smoothness of the sanitising composition by aiding the aqueous solubility of the other components, in particular the Polyquaternium-37 thickening component (see below), and enabling the sanitising composition to be made as a cold blend.
  • the active sanitising ingredient system may comprise one or more active sanitising ingredient components selected from polyaminopropyl biguanide, didecyl dimethyl ammonium chloride, benzalkonium chloride and parachlorometaxylenol.
  • the active sanitising ingredient system may comprise a mixture of polyaminopropyl biguanide, didecyl dimethyl ammonium chloride, benzalkonium chloride and parachlorometaxylenol.
  • the invention provides a sanitising composition
  • a sanitising composition comprising a carrier comprising a cyclic polysiloxane, and the composition further including an active sanitising ingredient system and wherein the active sanitising system includes two or more quaternary ammonium compounds selected from polyaminopropyl biguanide, didecyldimethyl ammonium chloride and benzalkonium chloride and wherein the active sanitising system further includes parachlorometaxylenol.
  • the invention provides a sanitising composition
  • a sanitising composition comprising a carrier comprising a cyclic polysiloxane, the composition further including an active sanitising ingredient system and wherein the active sanitising system includes polyaminopropyl biguanide, didecyldimethyl ammonium chloride and benzalkonium chloride and wherein the active sanitising system further includes parachlorometaxylenol and optionally methoxymethylbutanol .
  • the sanitising composition may further comprise a chelating agent, for example EDTA.
  • EDTA may potentiate the antimicrobial effect of the one or more active sanitising ingredient components.
  • the EDTA salt is dipotassium EDTA dihydrate.
  • the active sanitising ingredient system may be present in the sanitising composition in an amount in the range of 0.05 wt. % to 2.5 wt. %, desirably 1.5 wt. % to 2.5 wt. %, and advantageously substantially 2.05 wt. %.
  • the polyaminopropyl biguanide may be present in the sanitising composition in an amount in the range 0.05 wt. % to 1.0 wt. %, desirably 0.3 wt. % to 0.5 wt. % and advantageously substantially 0.4 wt. %.
  • the polyaminopropyl biguanide may be present in the sanitising composition in an amount in the range 0.01 wt. % to 0.3 wt. %.
  • the didecyl dimethyl ammonium chloride may be present in the sanitising composition in an amount in the range 0.05 wt. % to 1.0 wt. %, desirably 0.3 wt.
  • the didecyl dimethyl ammonium chloride may be present in the sanitising composition in an amount in the range 0.01 wt. % to 0.4 wt. %.
  • the chlorhexidine digluconate may be present in the sanitising composition in an amount in the range 0.05 wt. % to 1.0 wt. %, desirably 0.4 wt. % to 0.6 wt. % and advantageously substantially 0.5 wt. %.
  • the benzalkonium chloride may be present in the sanitising composition in an amount in the range 0.01 wt. % to 0.2 wt. %, desirably 0.05 wt. % to 0.15 wt. % and advantageously substantially 0.1 wt. %.
  • the benzalkonium chloride may be present in the sanitising composition in an amount in the range 0.01 wt. % to 0.1 wt. %.
  • the benzalkonium chloride may have a carbon chain length of C 12 to C 16 .
  • the chlorophenol e.g. parachlorometaxylenol
  • the chlorophenol may be present in the sanitising composition in an amount in the range 0.01 wt. % to 2 wt. %, desirably 0.01 wt. % to 0.2 wt. %, for example 0.01 wt. % to 0.1 wt. %, and advantageously substantially 0.094 wt. %.
  • the methoxymethylbutanol may be present in the sanitising composition in an amount in the range 0.01wt% to 90wt%, desirably 0.01 wt. % to 20 wt. %, for example 1 wt. % to 10 wt. % and advantageously substantially 8.1 wt. %.
  • the sanitising composition may be in the form of a gel, such as a hand gel.
  • the sanitising composition may include a thickener, which may be miscible in a
  • the thickener may comprise a hydrophilic thickener component, which may be cationic.
  • the hydrophilic thickener component may comprise a polyquaternium substance.
  • the hydrophilic thickener component may comprise polyquaternium-37 (for example sold under the trade name Kleasol 100XT).
  • the thickener may also constitute a film forming substance.
  • the thickener may comprise a hydrophobic thickener component, which may be non-ionic.
  • the hydrophobic thickener component may comprise an ethylene oxide/propylene oxide copolymer.
  • the hydrophobic thickener component may comprise PEG PPG- 19/ 19 dimethicone (for example sold under the trade name, DC BY 1 1-030).
  • the thickener may be present in the composition in an amount in the range of 0.05 wt. % to 5.0 wt. %, desirably 2.0 wt. % to 4.0 wt. %, and advantageously substantially 2.75 wt. %.
  • the hydrophilic thickener component may be present in the sanitising composition in an amount in the range 0.05 wt. % to 5.0 wt. %, desirably 1.0 wt. % to 2.0 wt. % and advantageously substantially 1.5 wt. %.
  • the hydrophobic thickener component may be present in the sanitising composition in an amount in the range 0.05 wt. % to 3.0 wt. %, desirably 0.5 wt. % to 2.0 wt. % and advantageously substantially 1.25 wt. %.
  • the sanitising composition may include a physiological coolant for example menthyl lactate.
  • the physiological coolant may be present in the sanitising composition in an amount in the range 0.05 wt. % to 1.0 wt. %, desirably 0.1 wt. % to 0.5 wt. % and advantageously substantially 0.25 wt. %.
  • the sanitising composition may include other ingredients, such as colorants and/or fragrances.
  • the sanitising composition does not contain ethanol and/or isopropyl alcohol (IPA).
  • IPA isopropyl alcohol
  • a sanitising composition which is in the form of an alcohol-free, specifically ethanol and isopropyl alcohol (IPA)-free, hand gel.
  • the invention further provides a hand gel comprising a sanitising composition according to the invention.
  • the hand gel comprises a sanitising composition comprising a cyclic polysiloxane, a thickener and an active sanitising ingredient system wherein the active sanitising system includes polyaminopropyl biguanide, didecyldimethyl ammonium chloride and benzalkonium chloride and wherein the active sanitising system further includes parachlorometaxylenol and optionally methoxymethylbutanol.
  • a further aspect of the invention provides a sanitising composition, which is in the form of an alcohol-free, specifically ethanol and isopropyl alcohol (IPA)-free, liquid, spray or foam.
  • the sanitising composition comprising a cyclic polysiloxane and an active sanitising ingredient system wherein the active sanitising system includes polyaminopropyl biguanide, didecyldimethyl ammonium chloride and benzalkonium chloride and wherein the active sanitising system further includes parachlorometaxylenol and optionally methoxymethylbutanol.
  • the sanitising composition may be used to impregnate a textile substrate.
  • the invention encompasses a sanitising wipe, such as a hand wipe, or tissue comprising a sanitising composition according to the invention.
  • a further aspect of the invention provides a hand wipe comprising a sanitising composition according to the invention.
  • the method may comprise forming a hydrophilic component system comprising water and an active ingredient.
  • the method may comprise forming a hydrophobic component system comprising a cyclic polysiloxane.
  • the method may comprise mixing the hydrophilic component system and the hydrophobic component system with each other.
  • the step forming the hydrophilic component system may comprise mixing a hydrophilic component thickener with the water and the active sanitising ingredient system.
  • the step of forming the hydrophobic component system may comprise mixing the hydrophobic thickener component with the cyclic polysiloxane.
  • the step of forming the hydrophilic component system may comprise mixing the hydrophilic thickener component with water. This step may comprise sprinkling the hydrophilic thickener component in a vessel containing water. The water may be continuously stirred during said mixing.
  • the method of forming the hydrophilic component system may comprise mixing each active sanitising ingredient component sequentially in the water. The step of mixing each active sanitising ingredient component sequentially may be performed after the mixing of the hydrophilic thickener component with the water.
  • the step of forming the hydrophobic component system may comprise adding the hydrophobic thickener component to the cyclic polysiloxane.
  • the step of forming the hydrophobic component system may comprise adding the physiological coolant to the cyclic polysiloxane, desirably after mixing the hydrophobic thickener component with the cyclic polysiloxane.
  • a sanitising composition in the form of an ethanol and IPA-free hand sanitising gel is described herein.
  • the sanitising composition comprises a carrier in the form of a cyclic polysiloxane, and an active sanitising ingredient system.
  • the cyclic polysiloxane may be cyclotetrasiloxane and/or cyclopentasiloxane.
  • Suitable cyclotetrasiloxanes and cyclopentasiloxanes are sold by the company Dow Xiameter. In the examples below, the cyclotetrasiloxane used is sold under the trade mark Xiameter PMX0244 and the cyclopentasiloxane used is sold under the trade mark Xiameter PMX0245.
  • the carrier is in the form of cyclotetrasiloxane, and is present in the sanitising composition in an amount of substantially 1.0 wt. %.
  • the active sanitising ingredient system may comprise one or more of the following active sanitising ingredient components: polyaminopropyl biguanide. didecyl dimethyl ammonium chloride, chlorhexidine digluconate and benzalkonium chloride.
  • One embodiment of the invention includes a mixture of each of the above active sanitising ingredient components.
  • Polyaminopropyl biguanide is commercially available as a 20 wt.
  • the amount of the commercially available aqueous solution used in the embodiment described below is substantially 1.5 wt. %.
  • Didecyl dimethyl ammonium chloride is commercially available as a 50 wt. % solution in water, and is sold under various the trade marks, such as, Bardac 22 and Acticide DDQ40.
  • didecyl dimethyl ammonium chloride is present in an amount of substantially 0.4 wt. %.
  • the amount of the commercially available aqueous solution used in the embodiment described below is substantially O.g wt. %.
  • Chlorhexidine digluconate is commercially available as a 20 wt. % solution in water, and is sold by the company Sigma Aldrich. In the example described below, chlorhexidine digluconate is present in an amount of substantially 0.5 wt. %. Thus, the amount of the commercially available aqueous solution used in the embodiment described below is substantially 2.5 wt. %.
  • Benzalkonium chloride is commercially available as a 50 wt. % solution in water, and is sold under various the trade marks, such as, Surfachem BAC50 and Acticide BAC50. In the example described below, benzalkonium chloride is present in an amount of substantially 0.1 wt. %. Thus, the amount of the commercially available aqueous solution used in the embodiment described below is substantially 0.2 wt. %.
  • the benzalkonium chloride has a carbon chain length of C 12 to C 16 .
  • the sanitising composition comprises a thickener, which is formed of a hydrophilic thickener component and a hydrophobic thickener component.
  • the hydrophilic thickener component is present in the sanitising composition in an amount of substantially 1.5 wt. %.
  • the hydrophobic thickener component is present in the sanitising composition in an amount of substantially 2.5 wt. %.
  • the hydrophilic thickener component comprises a cationic thickener component, and is in the form of polyquaternium-37.
  • a suitable such hydrophilic thickener component is sold under the trade mark Synthalen CR, manufactured by Coast Southwest, Placentia, CA, USA.
  • the hydrophobic thickener component comprises a non-ionic thickener component and is in the form of PEG/PPG- 19/19 Dimethicone.
  • a suitable such hydrophobic thickener component is sold by Dow Corning under the trade mark DC BY 1 1-030, and is in the form of a solution of PEG/PPG- 19/19 Dimethicone in cyclopentasiloxane, and partially provides the composition with its cyclopentasiloxane content.
  • the sanitising composition includes a physiological coolant, in the form of menthyl lactate.
  • the physiological coolant provides a cooling effect on the skin during use of the composition.
  • the physiological coolant is added in a crystalline form.
  • a suitable such physiological coolant is sold under the trade mark Frescolat ML Crystals 399952 by Symrise.
  • the amount of physiological coolant present in the sanitising composition is substantially 2.5 wt. %.
  • a hydrophilic component system comprising the following:
  • the method of forming the hydrophilic component system comprises adding the cold water to a vessel.
  • the polyquaternium-37 is then slowly sprinkled into the water in the vessel, while continuously mixing.
  • the polyquaternium-37 is allowed to completely hydrate and solubilise.
  • the active sanitising ingredients are added sequentially with continuous mixing between the additions of each active sanitising ingredient.
  • a hydrophobic component system is also formed, comprising the following:
  • the method of forming the hydrophobic component system comprises adding the cyclotetrasiloxane to a vessel.
  • the PEG/PPG-19/19 Dimethicone is then dissolved in the cyclotetrasiloxane while continuously stirring. Thereafter, the menthyl lactate crystals are added, also with continuous stirring.
  • the hydrophilic and the hydrophobic component systems are added to each other, with continuous stirring until a smooth homogeneous gel is produced.
  • a sanitising composition which is in the form of an alcohol-free sanitising hand gel.
  • the sanitising hand gel meets the requirements of EN1 00 - the prescribed test for hygienic hand-rubs, by achieving a log. 5 reduction of bacteria in the test or a performance equivalent to a reference material (Isopropyl alcohol).
  • the product is made in two phases. Firstly, a pre-mix containing non- water soluble ingredients is made. Secondly, an aqueous phase is made, to which is finally added the aqueous-phase pre-mix. Ingredient %w/w
  • a suitable vessel is charged with the Methoxymethylbutanol.
  • the PCMX is added, and stirred until completely dissolved.
  • the Xiameter PMX 0245 is added and stirred until completely assimilated and a homogenous clear solution is obtained.
  • the DC BY 11-030 is added and stirred until completely assimilated and a homogenous clear solution is obtained. This pre-mix is then set aside to be added at the end of the aqueous phase.
  • a suitable vessel is charged with the water (cold mains water or softened is acceptable).
  • the Dipotassium EDTA is added and the solution stirred until all the Dipotassium EDTA has dissolved.
  • the Methoxymethylbutanol is then added and stirred until the solution is clear and homogenous.
  • the Acticide PHB20 is then added and the solution is stirred until the solution is clear and homogenous.
  • the Kleasol 100XT is then added slowly by sprinkling into the solution with constant stirring. Stirring is maintained until the Kleasol has fully swollen and finally dissolved to give a more viscous solution, and until there is no undissolved material or 'fish-eyes' visible in the solution.
  • the Dipotassium EDTA is added and the solution stirred until all the Dipotassium EDTA has dissolved.
  • the Methoxymethylbutanol is then added and stirred until the solution is clear and homogenous.
  • the Acticide PHB20 is then added and the solution
  • Acticide DDQ40 is added and the solution stirred until all has been assimilated and the product is homogenous.
  • Acticide BAC50M is added and the solution stirred until all has been assimilated and the product is homogenous.
  • Phenoxyethanol is added slowly and with constant stirring until it has been assimilated and the product is homogenous. At this point, the product may go slightly more opaque.
  • the required amount of pre-mix (previously made and set aside) is added slowly and with constant stirring. Stirring is continued until the product is smooth and homogenous, and when all the pre-mix has been assimilated. The product may rise in viscosity due to the extra thicker in the non-aqueous phase being added.
  • Acticide PHB20 this is a 20% aqueous solution of Polyhexamethylene Biguanide
  • Acticide DDQ40 this is a 40% aqueous solution of Didecyldimethylammonium Chloride
  • Acticide BAC50M this is a 50% solution of the very widely used antimicrobial compound Benzalkonium Chloride.
  • Quaternary ammonium compounds are commonly used disinfectant compounds. It has been found that the combination of two or more of the above compounds gives a surprisingly better antimicrobial performance than any one on its own.
  • the sanitising composition may include other ingredients, such as colorants and/or fragrances.
  • Phase 1 An unthickened formulation is prepared as follows: Phase 1 :
  • Phases 1 and 2 are made separately then phase 2 is slowly added to phase 1 with constant stirring.
  • This formulation is suitable for dispensing as a liquid, spray, for example an aerosol, a hand wipe or a foam.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une composition désinfectante comprenant un véhicule comprenant un polysiloxane cyclique, la composition comprenant en outre un système de composant désinfectant actif.
EP12719416.5A 2011-02-23 2012-02-15 Composition désinfectante Withdrawn EP2710107A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1103123.4A GB201103123D0 (en) 2011-02-23 2011-02-23 Sanitising composition
GBGB1118303.5A GB201118303D0 (en) 2011-10-24 2011-10-24 Sanitising composition
PCT/GB2012/000157 WO2012114062A1 (fr) 2011-02-23 2012-02-15 Composition désinfectante

Publications (1)

Publication Number Publication Date
EP2710107A1 true EP2710107A1 (fr) 2014-03-26

Family

ID=46045021

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12719416.5A Withdrawn EP2710107A1 (fr) 2011-02-23 2012-02-15 Composition désinfectante

Country Status (2)

Country Link
EP (1) EP2710107A1 (fr)
WO (1) WO2012114062A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3949733A1 (fr) * 2020-08-06 2022-02-09 JVS Products Limited Compositions désinfectantes
DK3945821T3 (da) * 2020-06-03 2022-10-10 Jvs Products Ltd Desinfektionssammensætninger
EP3918916A1 (fr) * 2020-06-03 2021-12-08 JVS Products Limited Compositions
US20230140928A1 (en) * 2021-11-05 2023-05-11 Henkel IP & Holding GmbH Method For Determining Stability Of A Liquid Fabric Softener Formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040223935A1 (en) * 2003-04-09 2004-11-11 L'oreal Cosmetic composition containing a fatty acid glyceride, an alcohol and a silicone emulsifier
US20050271609A1 (en) * 2004-06-08 2005-12-08 Colgate-Palmolive Company Water-based gelling agent spray-gel and its application in personal care formulation
DE102007011491A1 (de) * 2007-03-07 2008-09-11 Henkel Ag & Co. Kgaa Verbesserter Glasreiniger
GB2453038B (en) * 2007-09-17 2011-03-09 Byotrol Plc Formulations comprising an anti-microbial composition
WO2011083401A2 (fr) * 2010-01-10 2011-07-14 Bclean Projects Ltd. Composition et distributeur pour hygiène intime

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2012114062A1 *

Also Published As

Publication number Publication date
WO2012114062A1 (fr) 2012-08-30

Similar Documents

Publication Publication Date Title
TWI498423B (zh) 抗微生物性組成物
JP5925758B2 (ja) 抗菌性組成物
CN104244921B (zh) 包含硅氧烷聚酯的发泡制剂
US8679516B2 (en) High alcohol content foaming compositions with silicone-based surfactants
AU2013240278B2 (en) Cationic antimicrobial handwash
JP5816758B2 (ja) 非エアゾールの泡状のアルコール手指消毒剤
TW200808329A (en) Composition and method for pre-surgical skin disinfection
WO2009050447A2 (fr) Produits pour la peau à base d'eau
JP2010529262A (ja) 持続効果の消毒洗浄剤
BR112019000849B1 (pt) Composições líquidas de limpeza com sistema antibacteriano e método de fabricação das mesmas
WO2012114062A1 (fr) Composition désinfectante
CN104220042A (zh) 包含硅氧烷基聚氨酯的发泡制剂
FI128215B (en) Low alcohol disinfection foam
US20170280715A1 (en) Hand sanitizer composition and method of manufacture
WO2021260141A1 (fr) Composition
KR20210008251A (ko) 보습 작용과 살균 작용을 동시에 가지는 무에탄올 손 소독제 및 그 제조방법
US9497962B1 (en) Hydroalcoholic foaming sanitizer
CN117323240A (zh) 一种纳米脂质体包裹的阳离子抗菌洗手液
CN101461765A (zh) 发用保湿定型啫喱膏
US20120077882A1 (en) Antibacterial agent-comprising powders and methods for manufacturing the same
WO2023276203A1 (fr) Composition de désinfectant pour les mains à base d'alcool à frictionner offrant une meilleure sensation
JP6533362B2 (ja) 皮膚身体殺菌洗浄剤組成物

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140812